| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.074 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.081 | 0.7 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.7 |